- Home
- NVO vs PDD Comparison
NVO vs PDD Comparison
Compare NVO & PDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | PDD |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | Denmark | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.7B | 167.0B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NVO | PDD |
|---|---|---|
| Price | $59.81 | $118.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 11 |
| Target Price | $54.25 | ★ $137.55 |
| AVG Volume (30 Days) | ★ 17.9M | 8.4M |
| Earning Date | 02-04-2026 | 11-18-2025 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | ★ 10.06 | N/A |
| EPS | 3.67 | ★ 9.68 |
| Revenue | $49,580,393,058.00 | ★ $58,790,822,784.00 |
| Revenue This Year | $7.25 | $10.73 |
| Revenue Next Year | $0.24 | $14.94 |
| P/E Ratio | $16.18 | ★ $12.45 |
| Revenue Growth | ★ 16.64 | 12.48 |
| 52 Week Low | $43.08 | $87.11 |
| 52 Week High | $93.80 | $139.41 |
Technical Indicators
Market Signals| Indicator | NVO | PDD |
|---|---|---|
| Relative Strength Index (RSI) | 77.51 | 53.64 |
| Support Level | $50.55 | $118.86 |
| Resistance Level | $60.64 | $125.36 |
| Average True Range (ATR) | 1.31 | 3.14 |
| MACD | 0.92 | 1.27 |
| Stochastic Oscillator | 93.95 | 54.28 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.